These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 28672766

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).
    Spadaccio C, Patti G, De Marco F, Coccia R, Di Domenico F, Pollari F, Zanzonico R, Pettinari M, Lusini M, Di Sciascio G, Covino E, Chello M.
    Am J Cardiol; 2013 Jul 01; 112(1):21-6. PubMed ID: 23561587
    [Abstract] [Full Text] [Related]

  • 4. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y, Iijima R, Shiba M, Nakamura M, Sugi K.
    J Cardiol; 2010 May 01; 55(3):391-6. PubMed ID: 20350511
    [Abstract] [Full Text] [Related]

  • 5. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP, Xu WT, Wang L, Li H, Shao CL, Gu HB, Chan SP, Xu HF, Yang XJ.
    Coron Artery Dis; 2015 Jan 01; 26(1):5-10. PubMed ID: 25211654
    [Abstract] [Full Text] [Related]

  • 6. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
    Zhu Y, Liu K, Chen M, Liu Y, Gao A, Hu C, Li H, Zhu H, Han H, Zhang J, Zhao Y.
    Cardiovasc Diabetol; 2021 Jul 08; 20(1):137. PubMed ID: 34238294
    [Abstract] [Full Text] [Related]

  • 7. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.
    Araki T, Nakamura M, Sugi K.
    J Cardiol; 2014 Dec 08; 64(6):423-9. PubMed ID: 24794755
    [Abstract] [Full Text] [Related]

  • 8. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Chen T, Sun JL, Zhang J.
    Coron Artery Dis; 2020 Nov 08; 31(7):586-589. PubMed ID: 32271235
    [Abstract] [Full Text] [Related]

  • 9. [Role of eosinophil granulocytes in the occurrence of restenosis in patients after coronary stenting with drug-eluting stents].
    Gabbasov ZA, Kozlov SG, Imaeva AÉ, Saburova OS, Masenko VP.
    Ter Arkh; 2014 Nov 08; 86(9):90-6. PubMed ID: 25518512
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M, Pross V, Marx N, Hoffmann R.
    Coron Artery Dis; 2012 Nov 08; 23(7):492-6. PubMed ID: 22990414
    [Abstract] [Full Text] [Related]

  • 12. Impact of coronary collateral circulation on angiographic in-stent restenosis in patients with stable coronary artery disease and chronic total occlusion.
    Yang ZK, Shen Y, Hu J, Zhang Q, Ding FH, Zhang RY, Lu L, Shen WF.
    Int J Cardiol; 2017 Jan 15; 227():485-489. PubMed ID: 27836292
    [Abstract] [Full Text] [Related]

  • 13. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
    Song T, Fu Y, Wang Y, Li W, Zhao J, Wang X, Wang H, Zhao Y, Fu X.
    BMC Cardiovasc Disord; 2021 Jan 07; 21(1):24. PubMed ID: 33413149
    [Abstract] [Full Text] [Related]

  • 14. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents.
    Wu XA, Xie G, Li XQ, Wu HT, Wang X.
    Clin Chim Acta; 2018 Apr 07; 479():20-24. PubMed ID: 29305846
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M, Nienaber CA, Mostafa AE, Sabin G, Tebbe U, Hochadel M, Senges J, Akin I, Kuck KH, Hamm C, Richardt G, German Drug-Eluting Stent (DES.DE) registry.
    EuroIntervention; 2011 Jun 07; 7(2):201-8. PubMed ID: 21646062
    [Abstract] [Full Text] [Related]

  • 16. Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study.
    Xie F, Yu Z, Xiong Y, Wu Z, Wu Y.
    Eur J Med Res; 2024 Feb 26; 29(1):145. PubMed ID: 38409069
    [Abstract] [Full Text] [Related]

  • 17. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
    Song HG, Kang SJ, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2014 May 01; 83(6):873-8. PubMed ID: 22815193
    [Abstract] [Full Text] [Related]

  • 18. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, García-Touchard A, López-Mínguez JR, Masotti M, Zueco J, Melgares R, Mainar V, Moreno R, Domínguez A, Sanchís J, Bethencourt A, Moreu J, Cequier A, Martí V, Otaegui I, Bastante T, Gonzalo N, Jiménez-Quevedo P, Cárdenas A, Fernández C, under the auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology.
    Circ Cardiovasc Interv; 2016 Jul 01; 9(7):. PubMed ID: 27412868
    [Abstract] [Full Text] [Related]

  • 19. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
    Watanabe Y, Takagi K, Naganuma T, Kawamoto H, Fujino Y, Ishiguro H, Tahara S, Kurita N, Hosawa K, Nakamura S, Nakamura S.
    Int J Cardiol; 2017 Aug 01; 240():108-113. PubMed ID: 28476515
    [Abstract] [Full Text] [Related]

  • 20. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.
    Remkes WS, Somi S, Roolvink V, Rasoul S, Ottervanger JP, Gosselink AT, Hoorntje JC, Dambrink JH, de Boer MJ, Suryapranata H, van 't Hof AW, Acute Myocardial Infarction Study Group.
    JACC Cardiovasc Interv; 2014 Jul 01; 7(7):751-8. PubMed ID: 25060017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.